脂肪性肝炎(Steatohepatitis):世界の治験レビュー(2015年上半期版)

【英語タイトル】Steatohepatitis Global Clinical Trials Review, H1, 2015

GlobalDataが出版した調査資料(GDHC2545CTIDB)・商品コード:GDHC2545CTIDB
・発行会社(調査会社):GlobalData
・発行日:2015年1月31日
・ページ数:79
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥540,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥810,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、世界における脂肪性肝炎(Steatohepatitis) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 脂肪性肝炎(Steatohepatitis)
  - 当レポートの概要
・脂肪性肝炎(Steatohepatitis):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Steatohepatitis Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Steatohepatitis Global Clinical Trials Review, H1, 2015″ provides data on the Steatohepatitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Steatohepatitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Steatohepatitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Steatohepatitis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Steatohepatitis to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Steatohepatitis to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Steatohepatitis 25
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Steatohepatitis Therapeutics Clinical Trials 32
Prominent Drugs 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Genextra S.p.a. 34
Clinical Trial Overview of Genextra S.p.a. 34
Galmed International Ltd. 35
Clinical Trial Overview of Galmed International Ltd. 35
Raptor Pharmaceuticals Corp. 36
Clinical Trial Overview of Raptor Pharmaceuticals Corp. 36
Immuron Limited 37
Clinical Trial Overview of Immuron Limited 37
Genfit SA 38
Clinical Trial Overview of Genfit SA 38
Cempra, Inc. 39
Clinical Trial Overview of Cempra, Inc. 39
Phenex Pharmaceuticals AG 40
Clinical Trial Overview of Phenex Pharmaceuticals AG 40
Gilead Sciences, Inc. 41
Clinical Trial Overview of Gilead Sciences, Inc. 41
F. Hoffmann-La Roche Ltd. 42
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 42
Catalysis, S.L. 43
Clinical Trial Overview of Catalysis, S.L. 43
Clinical Trial Overview of Top Institutes / Government 44
The National Institute of Diabetes and Digestive and Kidney Diseases 44
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 44
Tehran University of Medical Sciences 45
Clinical Trial Overview of Tehran University of Medical Sciences 45
University of California, San Diego 46
Clinical Trial Overview of University of California, San Diego 46
Hadassah Medical Organization 47
Clinical Trial Overview of Hadassah Medical Organization 47
Yokohama City University 48
Clinical Trial Overview of Yokohama City University 48
Institute of Liver and Biliary Sciences 49
Clinical Trial Overview of Institute of Liver and Biliary Sciences 49
National Nutrition and Food Technology Research Institute 50
Clinical Trial Overview of National Nutrition and Food Technology Research Institute 50
University Health Network 51
Clinical Trial Overview of University Health Network 51
U.S. Department of Veterans Affairs 52
Clinical Trial Overview of U.S. Department of Veterans Affairs 52
University of Michigan 53
Clinical Trial Overview of University of Michigan 53
Five Key Clinical Profiles 54
Appendix 77
Abbreviations 77
Definitions 77
Research Methodology 78
Secondary Research 78
About GlobalData 79
Contact Us 79
Disclaimer 79
Source 79

List of Tables
Steatohepatitis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Steatohepatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Steatohepatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Steatohepatitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Steatohepatitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Steatohepatitis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Steatohepatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Steatohepatitis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Steatohepatitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Steatohepatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Steatohepatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Steatohepatitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Steatohepatitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Steatohepatitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Steatohepatitis Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Steatohepatitis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Steatohepatitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Steatohepatitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Steatohepatitis Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Steatohepatitis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
Steatohepatitis Therapeutics, Global, Terminated Clinical Trials, 2015* 27
Steatohepatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Steatohepatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30
Steatohepatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Steatohepatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Steatohepatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Genextra S.p.a., 2015* 34
Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Galmed International Ltd., 2015* 35
Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Raptor Pharmaceuticals Corp., 2015* 36
Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Immuron Limited, 2015* 37
Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Genfit SA, 2015* 38
Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cempra, Inc., 2015* 39
Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Phenex Pharmaceuticals AG, 2015* 40
Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2015* 41
Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015* 42
Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Catalysis, S.L., 2015* 43
Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 44
Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 45
Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2015* 46
Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2015* 47
Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University, 2015* 48
Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Liver and Biliary Sciences, 2015* 49
Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Nutrition and Food Technology Research Institute, 2015* 50
Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2015* 51
Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2015* 52
Steatohepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2015* 53

List of Figures
Steatohepatitis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Steatohepatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Steatohepatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Steatohepatitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Steatohepatitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Steatohepatitis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Steatohepatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Steatohepatitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Steatohepatitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Steatohepatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Steatohepatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Steatohepatitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Steatohepatitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Steatohepatitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Steatohepatitis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Steatohepatitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Steatohepatitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Steatohepatitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Steatohepatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 29
Steatohepatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30
Steatohepatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Steatohepatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Steatohepatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
GlobalData Methodology 78

【レポートのキーワード】

脂肪性肝炎(Steatohepatitis)、治験、臨床試験、治験、治療薬

★調査レポート[脂肪性肝炎(Steatohepatitis):世界の治験レビュー(2015年上半期版)] (コード:GDHC2545CTIDB)販売に関する免責事項を必ずご確認ください。
★調査レポート[脂肪性肝炎(Steatohepatitis):世界の治験レビュー(2015年上半期版)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆